uniQure NV (QURE)
5.73
+0.16
(+2.87%)
USD |
NASDAQ |
Nov 05, 14:39
uniQure Profit Margin (Quarterly): -506.0% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -506.0% |
March 31, 2024 | -773.3% |
December 31, 2023 | -1.09K% |
September 30, 2023 | -6.37K% |
June 30, 2023 | -2.83K% |
March 31, 2023 | -1.45K% |
December 31, 2022 | 6.63% |
September 30, 2022 | -3.30K% |
June 30, 2022 | -7.86K% |
March 31, 2022 | -2.60K% |
December 31, 2021 | 14.23% |
September 30, 2021 | -1.84K% |
June 30, 2021 | 86.12% |
March 31, 2021 | -9.15K% |
December 31, 2020 | -2.05% |
September 30, 2020 | -3.01K% |
June 30, 2020 | -2.77K% |
March 31, 2020 | -26.92K% |
December 31, 2019 | -1.58K% |
September 30, 2019 | -2.26K% |
June 30, 2019 | -1.27K% |
March 31, 2019 | -2.44K% |
December 31, 2018 | -1.36K% |
Date | Value |
---|---|
September 30, 2018 | -700.0% |
June 30, 2018 | -675.1% |
March 31, 2018 | -540.2% |
December 31, 2017 | -1.06K% |
September 30, 2017 | -453.3% |
June 30, 2017 | -430.4% |
March 31, 2017 | -610.4% |
December 31, 2016 | -161.2% |
September 30, 2016 | -211.5% |
June 30, 2016 | -473.6% |
March 31, 2016 | -519.2% |
December 31, 2015 | -441.5% |
September 30, 2015 | -820.4% |
June 30, 2015 | -1.17K% |
March 31, 2015 | -1.14K% |
December 31, 2014 | -820.7% |
September 30, 2014 | -905.0% |
June 30, 2014 | -862.8% |
March 31, 2014 | -669.1% |
December 31, 2013 | -774.9% |
September 30, 2013 | -544.3% |
June 30, 2013 | -1.03K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-26.92K%
Minimum
Mar 2020
86.12%
Maximum
Jun 2021
-3.79K%
Average
-1.84K%
Median
Sep 2021
Profit Margin (Quarterly) Benchmarks
ProQR Therapeutics NV | -42.70% |
Merus NV | -848.7% |
argenx SE | 15.95% |
Pharming Group | -1.38% |
Pharvaris NV | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -132.6% |
Return on Assets | -34.33% |
Return on Invested Capital | -89.95% |
Gross Profit Margin (Quarterly) | 32.94% |
Operating Margin (Quarterly) | -395.6% |
Return on Net Operating Assets | -139.6% |